Details for Patent: 8,729,305

Title:	Process for the preparation of and crystalline forms of optical enantiomers of modafinil
Abstract:	The invention relates to a polymorphic form of (-)-modafinil that produces a powder X-ray diffraction spectrum comprising intensity peaks corresponding to interplanar spacings of about 14.14, 10.66, 7.80 and 4.02 .ANG., and a process for the preparation thereof.
Inventor(s):	Leproust; Pierre (Creteil, FR), Neckebrock; Olivier (Pontault Combault, FR)
Assignee:	Teva Sante (La Defense Cedex (Paris), FR)
Filing Date:	Apr 08, 2013
Application Number:	13/858,483
Claims:	1. A dextrorotatory enantiomer of modafinil in a polymorphic form that produces a powder X-ray diffraction spectrum comprising intensity peaks at the interplanar spacings: 8.54, 4.27, 4.02, 3.98 (.ANG.). 2. The dextrorotatory enantiomer of modafinil according to claim 1, wherein the polymorphic form produces a powder X-ray diffraction spectrum further comprising intensity peaks at the interplanar spacings: 13.40, 6.34, 5.01, 4.68, 4.62, 4.44, 4.20, 4.15, 3.90, 3.80, 3.43 (.ANG.). 3. A dextrorotatory enantiomer of modafinil in a polymorphic form that produces a powder X-ray diffraction spectrum comprising reflections at 15.4, 31.1, 33.1 and 33.4 degrees 2.theta.. 4. The dextrorotatory enantiomer of modafinil according to claim 3, wherein the polymorphic form produces a powder X-ray diffraction spectrum further comprising reflections at 9.8, 20.8, 26.4, 28.3, 28.7, 29.9, 31.6, 32, 34.1, 35.1 and 39 degrees 2.theta.. 5. A pharmaceutical composition comprising a dextrorotatory enantiomer of modafinil according to any one of claims 1 to 4. 6. A pharmaceutical composition consisting essentially of a dextrorotatory enantiomer of modafinil according to according to any one of claims 1 to 4. 7. A Form I polymorph of (+)-modafinil. 8. A pharmaceutical composition comprising a Form I polymorph of (+)-modafinil according to claim 7. 9. A pharmaceutical composition consisting essentially of a Form I polymorph of (+)-modafinil according to claim 7. 10. A process for preparing a Form I polymorph of (+)-modafinil comprising the steps of: (a) providing a solution of (+)-modafinil dissolved in a hot solvent; (b) rapidly cooling the solution from step (a) to produce crystals; (c) filtering the crystals; (d) drying the crystals; and (e) obtaining the crystals of said Form I polymorph of (+)-modafinil, wherein the solvent of step (a) is selected from water, methanol, absolute ethanol, absolute ethanol plus 3% water (v/v), and ethanol denatured with toluene plus 3% water, (v/v, based on the total volume of ethanol and toluene).